Former senior executive in leading global PR and public affairs consultancies, advising global healthcare industry and NGOs on communications, reputation and brand positioning strategies as well as public health campaigns, health advocacy and policy development issues. Jan. 2005, joined Novo Nordisk. Currently, Corporate Vice-President, Corporate Stakeholder Engagement,. Responsible for corporate sustainability, corporate public affairs, government affairs and trade policy. Directs the company's global access to diabetes care strategy. Responsible for the development and implementation of global Changing Diabetes® and Changing Possibilities in Haemophilia® leadership initiatives. Involved in initiatives promoting social change, particularly in the field of health and development. Council Member, Novo Nordisk Haemophilia Foundation. Member of Global Support Group, International Committee of the Red Cross.